Cargando…
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
OBJECTIVE: Recent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clarify the functional relevance and mechanistic acti...
Autores principales: | Li, Jiayu, Yuan, Xuhui, Ma, Cong, Li, Junhong, Qu, Gaoyang, Yu, Bo, Cai, Feng, Peng, Yuanxiang, Liu, Lang, Zeng, Duo, Jiao, QuanHui, Zhang, Jiongfeng, Luo, Xiaohui, Liao, Qi, Lv, Xiao-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079882/ https://www.ncbi.nlm.nih.gov/pubmed/37035213 http://dx.doi.org/10.3389/fonc.2023.1139588 |
Ejemplares similares
-
VDAC1 is regulated by BRD4 and contributes to JQ1 resistance in breast cancer
por: Yang, Guochao, et al.
Publicado: (2019) -
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
por: Benito, E, et al.
Publicado: (2017) -
FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma
por: Zeng, Duo, et al.
Publicado: (2023) -
BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring
por: Qu, Mingli, et al.
Publicado: (2018) -
Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS
por: Yuan, Xuhui, et al.
Publicado: (2023)